Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 18, 2021 16:01 ET | Source: Kala Pharmaceuticals, Inc.

Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

WATERTOWN, Mass., Aug. 18, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement...
August 05, 2021 07:00 ET | Source: Kala Pharmaceuticals, Inc.

Kala Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update

-- EYSUVIS Prescriptions Increased by 93% Compared to First Quarter of 2021 ---- Further Expanded Commercial Coverage for EYSUVIS to More Than 96 Million Lives ---- Achieved $3.1 Million in Net...
August 04, 2021 08:00 ET | Source: Kala Pharmaceuticals, Inc.

Kala Pharmaceuticals to Present at Upcoming Investor Conferences in August

WATERTOWN, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative...
July 29, 2021 08:00 ET | Source: Kala Pharmaceuticals, Inc.

Kala Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call

WATERTOWN, Mass., July 29, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative...
July 19, 2021 16:01 ET | Source: Kala Pharmaceuticals, Inc.

Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

WATERTOWN, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement...